Tobacco industry’s investment in sweetness comes full circle
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2338 (Published 10 June 2019) Cite this as: BMJ 2019;365:l2338- Sven-Eric Jordt, associate professor of anaesthesiology, pharmacology, and cancer biology,
- Sairam Jabba, senior research associate, department of anaesthesiology
- Duke University School of Medicine, Durham, NC 27710-3094, USA
- sven.jordt{at}duke.edu
Nguyen and colleagues clearly describe how the tobacco industry marketing juggernaut firmly established artificially flavoured, sugar sweetened drinks as part of children’s diets, contributing to today’s obesity and diabetes epidemic.1
Tobacco companies sold their sugary beverage assets years ago, but this groundwork probably underlies today’s strong preference of adolescents and young adults for intensely flavoured and sweetened tobacco products marketed by the same companies, including Reynolds and Altria (which owns Philip Morris). …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.